Eastman Chemical Company (EMN) fair value analysis
S&P 500 · Updated 2026-10-19
EMN price how computed
Forward Fair Value verdict
UndervaluedEMN is trading at a 10–25% discount to estimated fair value.
Based on TickrTrends' weekly Forward Fair Value model.
- Last price
- $64.05
- Sector
- Basic Materials
- 12-month range
- $56.37–$81.36
- Market cap
- $7.38B
- From 52-week high
- -21.3%
- Shares outstanding
- 115M
- Rank in Basic Materials by discount to fair value
- #9 of 26
Last price is the 2026-10-01 month-start close, the freshest stored price; the chart runs through 2026-09-11.
Eastman Chemical Company manufactures and sells chemicals, fibers, and plastics used in products ranging from paints and coatings to textiles and consumer goods. The company operates manufacturing facilities and offices across North America, Europe, Asia Pacific, and other regions worldwide.
EMN currently ranks #9 of 26 Basic Materials stocks by discount to fair value. It has screened as Undervalued for 11 consecutive weekly runs.
Fundamentals (4 quarters) how computed
- Market cap
- $7.38B
- P/E (trailing)
- 13x
- Revenue (TTM)
- $8.86B
- Net margin
- 5.0%
- EPS (TTM)
- $4.95
- Gross margin
- 22.3%
- Debt / equity
- 0.86
- Revenue growth (3-yr avg)
- 3.7%
- Shares outstanding
- 115M
Derived indicators how computed
- Quality grade
- F
- Margin trend
- Contracting
- 52-week position
- The lower-middle quarter of its range
Technicals how computed
- RSI (14-day)
- 37 · neutral
- 50-day average
- $70.70
- 200-day average
- $70.82
- Moving-average state
- 50-day below 200-day (death cross state); price below both averages
What our data shows for EMN
- Our model validated 17 trailing price-to-earnings windows for EMN, built from quarterly earnings records.
- Shares are trading in the lower third of their 12-month price range of $56.37–$81.36.
- The 14-day relative strength index sits at a neutral 37.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for EMN
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
Recent EMN news
TickrTrends' derived news-sentiment signal for EMN is currently leaning positive, computed from recent coverage.
- ONWARD Medical Announces the Appointment of Fouad Azzam to its Board of Directors (manilatimes.net, 2026-10-21)
TickrTrends take: ONWARD Medical's board expansion reflects corporate governance activity that may influence investor perception of management quality and strategic direction, factors that valuation models consider when assessing company fundamentals. TickrTrends currently identifies EMN as undervalued within the Basic Materials sector, suggesting the market may not be fully pricing in operational developments or leadership changes at the company level. For valuation-focused investors, attention to how new board appointments translate into measurable operational improvements or strategic shifts in the Basic Materials space would be relevant to monitoring whether the undervalued assessment holds over time. - Eastman Chemical (EMN) Shares Drop 2.6% After J.P. Morgan Downgrade on Commodity Spread Concerns (gurufocus.com, 2026-10-16)
TickrTrends take: Eastman Chemical faces near-term headwinds from commodity spread pressure, which could test whether the market's undervalued assessment holds if the company's earnings prove more vulnerable to input cost dynamics than currently priced in. The downgrade reflects concerns about margin compression in an industry where feedstock costs significantly impact profitability, making it important to monitor how EMN's actual spreads evolve relative to analyst expectations. For those focused on valuation, the question becomes whether the undervalued designation accounts sufficiently for potential earnings pressure from the commodity environment that prompted J.P. Morgan's cautious stance. - EMN Downgraded by JP Morgan -- Price Target Lowered to $66.00 (gurufocus.com, 2026-10-16)
TickrTrends take: JP Morgan's downgrade of Eastman Chemical Company and reduction of its price target to $66 comes at a time when TickrTrends' valuation analysis indicates the stock is undervalued. For investors focused on valuation metrics, this analyst action represents a potential pressure point that could either validate or challenge the current undervalued assessment depending on how the broader market responds to the downgrade. The Basic Materials sector backdrop and any shifts in analyst sentiment warrant monitoring to understand whether the downgrade reflects temporary concerns or signals a fundamental reassessment of the company's value proposition.
More EMN news
- Eastman Chemical: The Market Is Overreacting To Suspected Downside (NYSE:EMN) (seekingalpha.com, 2026-10-14)
- EMN Initiated Coverage On by Barclays -- Rating Set to Equal-Weight (gurufocus.com, 2026-10-13)
- EMN Maintained by UBS -- Price Target Lowered to $77.00 (gurufocus.com, 2026-10-05)
What people are saying
Follow the EMN conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-06 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-28 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-21 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-17 — No material change this week: the verdict, bands and grades all held steady.
Frequently asked questions
Is EMN stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-10-19), EMN is trading at a 10–25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.
What is EMN's TickrTrends verdict?
EMN's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.
How does EMN compare to other Basic Materials stocks?
EMN ranks #9 of 26 Basic Materials stocks in TickrTrends' coverage by discount to fair value.
Is EMN overbought or oversold?
EMN's 14-day RSI is in neutral territory - neither overbought nor oversold.
More in Basic Materials
Head-to-head comparisons
EMN vs ALB · EMN vs APD · EMN vs BCPC · EMN vs ECL · EMN vs LIN